Literature DB >> 18040790

Neuroimmunity, drugs of abuse, and neuroAIDS.

Tricia H Burdo1, Simon N Katner, Michael A Taffe, Howard S Fox.   

Abstract

It has long been postulated that drugs of abuse may represent significant cofactors in the progression of human immunodeficiency virus (HIV)-induced disease. Both HIV infection and drugs of abuse have significant effect on the immune system as well as on the nervous system. In HIV infection, abnormalities in these systems intersect to lead to a constellation of symptoms known as neuroAIDS. Drugs of abuse may synergize with such damage, acting on immune and/or neural cells. However, definitive epidemiological evidence for such an interaction is lacking. Here we review such studies as well as the use of the nonhuman primate/simian immunodeficiency virus system to investigate the interaction of neuroAIDS with drugs of abuse. Furthermore, recent findings on mechanisms of actions of selected drugs reveal the possibility of protective as well as detrimental effects on the central nervous system damage induced by HIV.

Entities:  

Mesh:

Year:  2006        PMID: 18040790     DOI: 10.1007/s11481-005-9001-3

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  56 in total

1.  Controlled and behaviorally relevant levels of oral ethanol intake in rhesus macaques using a flavorant-fade procedure.

Authors:  Simon N Katner; Claudia T Flynn; Stefani N Von Huben; Amber J Kirsten; Sophia A Davis; Christopher C Lay; Maury Cole; Amanda J Roberts; Howard S Fox; Michael A Taffe
Journal:  Alcohol Clin Exp Res       Date:  2004-06       Impact factor: 3.455

Review 2.  Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms.

Authors:  A Nath; J Geiger
Journal:  Prog Neurobiol       Date:  1998-01       Impact factor: 11.685

3.  Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption.

Authors:  Rakesh Kumar; Antonio E Perez-Casanova; Grissell Tirado; Richard J Noel; Cynthia Torres; Idia Rodriguez; Melween Martinez; Silvija Staprans; Edmundo Kraiselburd; Yasuhiro Yamamura; J Dee Higley; Anil Kumar
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

4.  The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals.

Authors:  R B Nieman; J Fleming; R J Coker; J R Harris; D M Mitchell
Journal:  AIDS       Date:  1993-05       Impact factor: 4.177

5.  Does drug abuse alter microglial phenotype and cell turnover in the context of advancing HIV infection?

Authors:  I C Anthony; S N Ramage; F W Carnie; P Simmonds; J E Bell
Journal:  Neuropathol Appl Neurobiol       Date:  2005-06       Impact factor: 8.090

6.  Proinflammatory synergism of ethanol and HIV-1 Tat protein in brain tissue.

Authors:  Govinder Flora; Hong Pu; Yong Woo Lee; R Ravikumar; Avindra Nath; Bernhard Hennig; Michal Toborek
Journal:  Exp Neurol       Date:  2005-01       Impact factor: 5.330

7.  Cannabis use in HIV for pain and other medical symptoms.

Authors:  Emily Woolridge; Simon Barton; Jonathon Samuel; Jess Osorio; Andrew Dougherty; Anita Holdcroft
Journal:  J Pain Symptom Manage       Date:  2005-04       Impact factor: 3.612

8.  Monocytes, alcohol use, and altered immunity.

Authors:  G Szabo
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

9.  Effect of ethanol on monocytic function in human immunodeficiency virus type 1 infection.

Authors:  H Chen; I George; K Sperber
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.

Authors:  M C Grimm; A Ben-Baruch; D D Taub; O M Howard; J H Resau; J M Wang; H Ali; R Richardson; R Snyderman; J J Oppenheim
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  21 in total

Review 1.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 2.  Neurocognitive impact of antiretroviral treatment: thinking long-term.

Authors:  Megan E McPhail; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

3.  Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.

Authors:  Jason J Paris; Harminder D Singh; Amanda N Carey; Jay P McLaughlin
Journal:  Behav Brain Res       Date:  2015-05-22       Impact factor: 3.332

Review 4.  Investigational protease inhibitors as antiretroviral therapies.

Authors:  Narasimha M Midde; Benjamin J Patters; Pss Rao; Theodore J Cory; Santosh Kumar
Journal:  Expert Opin Investig Drugs       Date:  2016-08-02       Impact factor: 6.206

5.  Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.

Authors:  Scot McIntosh; Tammy Sexton; Lindsey P Pattison; Steven R Childers; Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2015-03-10       Impact factor: 4.147

6.  HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific.

Authors:  Douglas R Miller; Fatemeh Shaerzadeh; Leah Phan; Nesrin Sharif; Joyonna Gamble-George; Jay P McLaughlin; Wolfgang J Streit; Habibeh Khoshbouei
Journal:  Glia       Date:  2018-05-07       Impact factor: 7.452

7.  Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.

Authors:  Shiping Zou; Sylvia Fitting; Yun-Kyung Hahn; Sandra P Welch; Nazira El-Hage; Kurt F Hauser; Pamela E Knapp
Journal:  Brain       Date:  2011-11-18       Impact factor: 13.501

Review 8.  Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Authors:  Vishnudutt Purohit; Rao Rapaka; David Shurtleff
Journal:  Mol Neurobiol       Date:  2011-07-01       Impact factor: 5.590

9.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

10.  18O proteomics reveal increased human apolipoprotein CIII in Hispanic HIV-1+ women with HAART that use cocaine.

Authors:  Frances Zenón; Inmaculada Jorge; Ailed Cruz; Erick Suárez; Annabell C Segarra; Jesús Vázquez; Loyda M Meléndez; Horacio Serrano
Journal:  Proteomics Clin Appl       Date:  2015-11-19       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.